Personalising haemophilia management with shared decision making
The current standard of care for treating people with haemophilia (PWH) in the developed world is prophylaxis with regular infusions of clotting factor concentrates. Gene therapy is being investigated as a new treatment paradigm for haemophilia and if approved would potentially eliminate the need fo...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2021-06-01
|
Series: | The Journal of Haemophilia Practice |
Subjects: | |
Online Access: | https://doi.org/10.17225/jhp00178 |